Drug Shortage Report for VIOKACE

Last updated on 2018-10-09 History
Report ID 62330
Drug Identification Number 02241933
Brand name VIOKACE
Common or Proper name Viokace
Company Name APTALIS PHARMA CANADA ULC
Active Ingredient(s) AMYLASE PROTEASE LIPASE
Strength(s) 113400UNIT 112500UNIT 20880UNIT
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 count bottle
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-08-27
Estimated end date 2018-10-12
Actual end date 2016-10-05
Shortage status Avoided shortage
Updated date 2018-10-09
Company comments Production delay
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-10-09 French Compare
v3 2018-10-09 English Compare
v2 2018-09-25 French Compare
v1 2018-09-25 English Compare